Pinnacle Wealth Management Advisory Group LLC Acquires 183 Shares of Waters Co. (NYSE:WAT)

Pinnacle Wealth Management Advisory Group LLC increased its stake in shares of Waters Co. (NYSE:WAT) by 10.5% in the fourth quarter, Holdings Channel reports. The firm owned 1,922 shares of the medical instruments supplier’s stock after buying an additional 183 shares during the quarter. Pinnacle Wealth Management Advisory Group LLC’s holdings in Waters were worth $713,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in WAT. Kennebec Savings Bank acquired a new stake in shares of Waters in the 3rd quarter valued at approximately $33,000. Fortitude Family Office LLC raised its holdings in Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 66 shares during the period. Ashton Thomas Securities LLC bought a new position in shares of Waters during the third quarter worth $35,000. R Squared Ltd bought a new stake in shares of Waters in the 4th quarter valued at $63,000. Finally, Itau Unibanco Holding S.A. raised its stake in Waters by 63.2% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after buying an additional 72 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Price Performance

NYSE:WAT opened at $369.71 on Monday. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56. The stock’s 50 day moving average price is $389.84 and its two-hundred day moving average price is $364.75. The firm has a market capitalization of $21.95 billion, a price-to-earnings ratio of 35.28, a P/E/G ratio of 7.37 and a beta of 1.01.

Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.43% and a return on equity of 49.93%. On average, analysts anticipate that Waters Co. will post 11.79 earnings per share for the current year.

Wall Street Analyst Weigh In

WAT has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft raised their target price on shares of Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Stifel Nicolaus lifted their price target on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Barclays raised Waters from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $360.00 to $415.00 in a research report on Monday, February 10th. Wells Fargo & Company lifted their target price on Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a research report on Thursday. Finally, JPMorgan Chase & Co. raised their price target on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a research note on Monday, November 4th. Ten research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $390.40.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.